MTS Medication Tech. (MTSI) Tops Q4 Views

June 16, 2009 8:32 AM EDT

MTS Medication Technologies, Inc. (NASDAQ: MTSI) reports Q4 EPS of $0.13, 4 cents better than the analyst estimate of $0.09. Revenue for the quarter was $17 million, versus the consensus of $16.60 million.


Related Categories

Earnings

Stocks Mentioned

MTSI 5.72

-0.01 -0.17%
Volume: 40,300
Track MTSI


Add Your Comment